SAN FRANCISCO — Wilson Sonsini Goodrich & Rosati advised San Diego-based therapeutics company Otonomy Inc. in its initial public offering, the firm announced Wednesday.
The drug developer, focused on treating ear disorders and diseases, registered 6.25 million shares of public common stock at $16 per share. It began trading Wednesday on the Nasdaq Global Select Market under the symbol “OTIC.”
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
